Supplementation With L. Reuteri in H. Pylori Infected Adults

Inclusion Criteria: * Subjects aged 18-70 years * Infection with H. pylori defined by endoscopic examination with biopsy H. pylori staining * Non-ulcer dyspepsia * Absence of other pathology as shown by basic clinical laboratory tests (blood and urine) as well as abdominal ultrasound * No earlier eradication therapy for H. pylori infection * Written informed consent * Stated availability throughout the entire study period * Mental ability to understand and willingness to fulfil all the details of the protocol. Exclusion Criteria: * Duodenal or gastric ulcer * MALT lymphoma * Gastric resection (at any time) * First level relatives of gastric cancer patients * Absence of GI symptoms * Use of NSAIDs, aspirin or other anti-inflammatory drugs within 1 week (for occasional use) or 3 weeks (for chronic use) of inclusion * Use of oral antibiotics and/or PPIs and/or H2-antagonists during the 2 weeks prior to ingestion of the study product * Pregnancy * Participation in other clinical trials